T-Oasis Test Course

test

Pdf Summary

The document is an AAAP 2023 Conflict of Interest (COI) Disclosure Form (Reference #16364041; internal tracking 511023916_119450) completed by Andrew Saxon (asaxon@u.washington.edu). The submitter reports having had financial relationships with ineligible companies within the past 24 months. Disclosed relationships include: (1) UpToDate, Inc.—royalties for editorial work related to healthcare information; this relationship has not ended. (2) Lundbeck—consulting fees related to pharmaceuticals; this relationship has ended. (3) Boehringer Ingelheim—consulting fees related to pharmaceuticals; this relationship has not ended. The form reiterates that at least one relationship ended within the last 24 months (specifically Lundbeck), and no other professional or financial interests are disclosed.<br /><br />The submitter agrees to AAAP’s COI mitigation process if any relationships are deemed relevant. They also attest to multiple standards for accredited continuing education content, including basing patient care recommendations on current science and clinical reasoning, using credible balanced sources, adhering to accepted research standards, clearly identifying evolving or debated topics, avoiding unscientific or unsafe recommendations, describing level of evidence and study details, addressing risks/adverse effects, using generic names when possible, disclosing off-label use, and not promoting any ineligible company (including when trained/used as a speaker or presenting industry-funded research). The submitter acknowledges that live presentations may be monitored to ensure they are educational and not promotional.<br /><br />The form includes an attestation that the information is accurate as of submission. Metadata shows the form was completed on 2025-09-03 (start 16:56:40; finish 17:07:07), submitted from IP 152.131.18.43 using Edge on a desktop, via the AAAP education site (Formsite-powered).

Keywords

AAAP 2023

Conflict of Interest Disclosure

COI mitigation process

Andrew Saxon

UpToDate royalties

Lundbeck consulting fees

Boehringer Ingelheim consulting

ineligible companies

accredited continuing education standards

off-label use disclosure